3 Penny Stocks to Watch Now, 3/18/25
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 18 2025
0mins
Should l Buy SES?
Source: TipRanks
Penny Stocks to Watch: AirNet Technology, NanoVibronix, and SES AI Corporation are highlighted as top penny stocks on March 18, 2025, based on their high Dollar Volume and significant stock price increases.
Company Highlights: AirNet Technology is expanding into Bitcoin mining, NanoVibronix reported positive study results for its UroShield device, and SES AI Corporation is addressing compliance issues with the NYSE regarding its stock price.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SES?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SES
Wall Street analysts forecast SES stock price to rise
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.170
Low
4.00
Averages
4.00
High
4.00
Current: 1.170
Low
4.00
Averages
4.00
High
4.00
About SES
SES AI Corporation is a battery manufacturing company. The Company is a developer and manufacturer of high-performance, artificial intelligence (AI)-enhanced Lithium-Metal (Li-Metal) and Lithium-ion (Li-ion) rechargeable battery technologies for electric vehicles (EVs), Urban Air Mobility, drones, robotics, Battery Energy Storage Systems and other applications. It utilizes AI across the spectrum of its business, from research and development; materials sourcing; cell design; engineering and manufacturing; to battery health and safety monitoring. The Company's differentiated battery technology is designed to combine the high energy density of Li-Metal with the manufacturability of conventional Li-ion batteries. It produces large 50 Amp-hour (Ah) and 100Ah B-sample Li-Metal battery cells for EVs. Its AI programs fall under three major categories: AI for Science, AI for Manufacturing, and AI for Safety. The Company also specializes in premium energy storage systems.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
U.S. Stocks Rise as NIO Reports Strong Earnings
- Quarterly Revenue Surge: NIO reported quarterly revenue of 34.65 billion yuan ($4.95 billion), reflecting a year-over-year increase of 75.9% and a sequential rise of 59.0%, surpassing the analyst consensus estimate of $4.61 billion, indicating robust market demand and sales growth potential.
- Significant Earnings Improvement: The company's adjusted earnings came in at 0.29 yuan (4 cents) per ADS, a remarkable turnaround from a loss of 3.17 yuan per ADS a year earlier, exceeding expectations for a 5-cent loss, showcasing effective cost control and enhanced profitability.
- Stock Price Rally: Following the earnings report, NIO shares surged 10.6% to $5.47, reflecting investor optimism regarding the company's future growth prospects and potentially attracting more institutional investor interest.
- Overall Market Performance: The U.S. stock market rose overall, with the Dow Jones index gaining around 200 points on Tuesday, indicating increased confidence in economic recovery, which may provide a favorable investment environment for NIO and other tech stocks.
See More
Lisata Therapeutics to be Taken Private by Kuva Labs
- Acquisition Agreement: Lisata Therapeutics Inc has agreed to be taken private by Kuva Labs, offering shareholders $5.00 per share along with a $1.00 contingent value right per share, indicating recognition of the company's future potential.
- Significant Stock Surge: Following the acquisition announcement, Lisata Therapeutics' shares rose 20.3% in pre-market trading to $5.03, reflecting positive market reaction and increased investor confidence in the deal.
- Impact of Privatization: The acquisition will result in Lisata Therapeutics delisting from public markets, potentially providing the company with greater flexibility to focus on long-term strategic goals while mitigating the impact of market volatility on its operations.
- Market Dynamics Shift: The announcement of this deal has sparked interest in other related stocks, demonstrating investor enthusiasm for M&A activity in the biotech sector, which may influence future investment decisions and market trends.
See More
Middle East Conflict Drives Oil Prices Surge
- Oil Price Surge: The escalation of conflict in the Middle East has driven crude oil prices close to $90 per barrel within a week, marking one of the sharpest weekly gains in years, which directly threatens global energy supply and rattles investor confidence.
- Labor Market Deterioration: The U.S. labor market unexpectedly lost 92,000 nonfarm jobs in February, exacerbating concerns about weakening economic momentum and undermining market confidence in future economic prospects.
- Energy Stocks Rise: The surge in energy costs quickly impacted equity markets, lifting energy stocks while severely hitting fuel-sensitive sectors like airlines and cruise operators, as investors feared rising jet fuel prices would squeeze margins.
- Fragile Market Sentiment: The geopolitical shock has added to already fragile market sentiment, prompting traders to reassess inflation risks associated with rising oil prices and supply disruptions, leading to increased overall market volatility.
See More
Three Defense Stocks Priced Under $20 with Significant Growth Potential
Investment Opportunities: There are still opportunities to invest in small-cap defense stocks trading for less than $20, with companies like Red Cat Holdings and Amprius Technologies showing potential for growth.
Company Performance: Unusual Machines reported its first profitable quarter in Q3 2025, with significant revenue growth and a target of reaching $30 million in annual revenue.
Market Analysis: Analysts are optimistic about several defense stocks, including SES AI Corp, which is noted for its high-risk, high-reward potential, and is involved in developing advanced battery technologies for various applications.
Stock Recommendations: Market Beat has identified five defense stocks that analysts recommend buying now, suggesting they are poised for significant upside as the broader market catches on.
See More
SES AI Under Investigation Following Revenue Impact Disclosure
- Revenue Disruption: SES AI disclosed in its Q4 2025 earnings report that approximately $1.5 million in revenue was delayed to Q1 2026 due to logistics constraints, leading to a stock price drop that reflects market concerns over operational efficiency.
- Legal Investigation Initiated: Holzer & Holzer, LLC is investigating whether SES AI complied with federal securities laws, indicating potential legal risks that could further undermine investor confidence and stock performance.
- Investor Losses: Investors who purchased SES AI stock may face losses due to the revenue delay, prompting Holzer & Holzer to encourage affected investors to contact them to discuss their legal rights, highlighting a focus on investor protection.
- Reputation Risk: The transparency of SES AI's financials is under scrutiny, which may lead to difficulties in future financing and a decline in market trust, impacting its long-term strategic development and competitive position.
See More
SES AI Under Investigation for Potential Securities Law Violations
- Significant Stock Drop: SES AI Corporation's shares plummeted over 30% on March 5, 2026, following the release of Q4 and FY25 results, primarily due to logistics constraints that delayed shipments, pushing approximately $1.5 million in expected revenue into Q1 2026, which directly impacted investor confidence and the company's market capitalization.
- Investigation Background: Block & Leviton is investigating whether SES AI committed securities law violations, particularly regarding the company's failure to timely disclose the impact of shipment delays on revenue timing, which may have led investors to make investment decisions without fully understanding the risks involved.
- Investor Rights Protection: Investors who have incurred losses in SES AI are encouraged to contact Block & Leviton to learn how to seek legal recourse for their losses, demonstrating a commitment to protecting investor rights and interests.
- Whistleblower Program Incentives: SES AI's whistleblower program allows individuals with non-public information to report to the SEC, with potential rewards of up to 30% of any successful recovery, aiming to encourage more participation in the investigation and promote transparency and compliance.
See More
U.S. Stocks Rise as NIO Reports Strong Earnings
- Quarterly Revenue Surge: NIO reported quarterly revenue of 34.65 billion yuan ($4.95 billion), reflecting a year-over-year increase of 75.9% and a sequential rise of 59.0%, surpassing the analyst consensus estimate of $4.61 billion, indicating robust market demand and sales growth potential.
- Significant Earnings Improvement: The company's adjusted earnings came in at 0.29 yuan (4 cents) per ADS, a remarkable turnaround from a loss of 3.17 yuan per ADS a year earlier, exceeding expectations for a 5-cent loss, showcasing effective cost control and enhanced profitability.
- Stock Price Rally: Following the earnings report, NIO shares surged 10.6% to $5.47, reflecting investor optimism regarding the company's future growth prospects and potentially attracting more institutional investor interest.
- Overall Market Performance: The U.S. stock market rose overall, with the Dow Jones index gaining around 200 points on Tuesday, indicating increased confidence in economic recovery, which may provide a favorable investment environment for NIO and other tech stocks.
See More
Lisata Therapeutics to be Taken Private by Kuva Labs
- Acquisition Agreement: Lisata Therapeutics Inc has agreed to be taken private by Kuva Labs, offering shareholders $5.00 per share along with a $1.00 contingent value right per share, indicating recognition of the company's future potential.
- Significant Stock Surge: Following the acquisition announcement, Lisata Therapeutics' shares rose 20.3% in pre-market trading to $5.03, reflecting positive market reaction and increased investor confidence in the deal.
- Impact of Privatization: The acquisition will result in Lisata Therapeutics delisting from public markets, potentially providing the company with greater flexibility to focus on long-term strategic goals while mitigating the impact of market volatility on its operations.
- Market Dynamics Shift: The announcement of this deal has sparked interest in other related stocks, demonstrating investor enthusiasm for M&A activity in the biotech sector, which may influence future investment decisions and market trends.
See More
Middle East Conflict Drives Oil Prices Surge
- Oil Price Surge: The escalation of conflict in the Middle East has driven crude oil prices close to $90 per barrel within a week, marking one of the sharpest weekly gains in years, which directly threatens global energy supply and rattles investor confidence.
- Labor Market Deterioration: The U.S. labor market unexpectedly lost 92,000 nonfarm jobs in February, exacerbating concerns about weakening economic momentum and undermining market confidence in future economic prospects.
- Energy Stocks Rise: The surge in energy costs quickly impacted equity markets, lifting energy stocks while severely hitting fuel-sensitive sectors like airlines and cruise operators, as investors feared rising jet fuel prices would squeeze margins.
- Fragile Market Sentiment: The geopolitical shock has added to already fragile market sentiment, prompting traders to reassess inflation risks associated with rising oil prices and supply disruptions, leading to increased overall market volatility.
See More
Three Defense Stocks Priced Under $20 with Significant Growth Potential
Investment Opportunities: There are still opportunities to invest in small-cap defense stocks trading for less than $20, with companies like Red Cat Holdings and Amprius Technologies showing potential for growth.
Company Performance: Unusual Machines reported its first profitable quarter in Q3 2025, with significant revenue growth and a target of reaching $30 million in annual revenue.
Market Analysis: Analysts are optimistic about several defense stocks, including SES AI Corp, which is noted for its high-risk, high-reward potential, and is involved in developing advanced battery technologies for various applications.
Stock Recommendations: Market Beat has identified five defense stocks that analysts recommend buying now, suggesting they are poised for significant upside as the broader market catches on.
See More
SES AI Under Investigation Following Revenue Impact Disclosure
- Revenue Disruption: SES AI disclosed in its Q4 2025 earnings report that approximately $1.5 million in revenue was delayed to Q1 2026 due to logistics constraints, leading to a stock price drop that reflects market concerns over operational efficiency.
- Legal Investigation Initiated: Holzer & Holzer, LLC is investigating whether SES AI complied with federal securities laws, indicating potential legal risks that could further undermine investor confidence and stock performance.
- Investor Losses: Investors who purchased SES AI stock may face losses due to the revenue delay, prompting Holzer & Holzer to encourage affected investors to contact them to discuss their legal rights, highlighting a focus on investor protection.
- Reputation Risk: The transparency of SES AI's financials is under scrutiny, which may lead to difficulties in future financing and a decline in market trust, impacting its long-term strategic development and competitive position.
See More
SES AI Under Investigation for Potential Securities Law Violations
- Significant Stock Drop: SES AI Corporation's shares plummeted over 30% on March 5, 2026, following the release of Q4 and FY25 results, primarily due to logistics constraints that delayed shipments, pushing approximately $1.5 million in expected revenue into Q1 2026, which directly impacted investor confidence and the company's market capitalization.
- Investigation Background: Block & Leviton is investigating whether SES AI committed securities law violations, particularly regarding the company's failure to timely disclose the impact of shipment delays on revenue timing, which may have led investors to make investment decisions without fully understanding the risks involved.
- Investor Rights Protection: Investors who have incurred losses in SES AI are encouraged to contact Block & Leviton to learn how to seek legal recourse for their losses, demonstrating a commitment to protecting investor rights and interests.
- Whistleblower Program Incentives: SES AI's whistleblower program allows individuals with non-public information to report to the SEC, with potential rewards of up to 30% of any successful recovery, aiming to encourage more participation in the investigation and promote transparency and compliance.
See More
